Author:
Zapf Antonia,Röver Christian
Publisher
Springer Berlin Heidelberg
Reference99 articles.
1. Acheson J, Archibald D, Barnett H (1988) Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 256(6618):320–331
2. Anzures-Cabrera J, Higgins JPT (2010) Graphical displays for meta-analysis: an overview with suggestions for practice. Res Synth Methods 1(1):66–80. https://doi.org/10.1002/jrsm.6
3. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften eV (AWMF) (2022) Leitlinien. https://www.awmf.org/leitlinien. Zugegriffen am 12.09.2023
4. Attard G, Murphy L, Clarke N, Cross W, Jones R, et al (2022) Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the stampede platform protocol. The Lancet 399(10323):447–460. https://doi.org/10.1016/S0140-6736(21)02437-5
5. Baigent C, Blackwell L, Collins R, et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. The Lancet 373(9678):1849–1860. https://doi.org/10.1016/S0140-6736(09)60503-1